ePostersLive by SCIGEN TECHNOLOGIES
388 posters, 
12 sessions, 
2210 authors, 
613 institutions

PP001

WEIGHT CONTROL IN TYPE 2 DIABETES PATIENTS TREATED WITH INCRETIN MIMETICS

Thursday, 6 October, 2011 - 15:08
Board 1

,
Weight loss is a major therapeutic objective in type 2 diabetes. The presence of great obesity associated with type 2 diabetes significantly increases the risk of mortality. Weight loss of over 20% may even lead to the remission of diabetes also decreases the overall mortality rate by 30-40%, increasing life expectancy and quality of life. This paper aims to follow the influence of weight loss on the metabolic balance in patients with type 2 diabetes treated with Incretin Mimetics.
Your rating: None Average: 4.3 (4 votes)